US$ 29.62
glp-1/gcgr dual agonist Media Centre Structural comparison of GIPR, GLP-1R
Description
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial

2015, Smith et al

Stensen S, Gasbjerg LS, Helsted MM, Hartmann B, Christensen MB, Knop FK

If additional glycemic control is needed, the dose may be increased to 1 mg weekly after at least four weeks, and potentially to a maximum of 2 mg weekly

F., & STEP 1 Study Group (2021)

Diabetes Obes Metab 2013;15:770-3.ArticlePubMed 113
